ResearcherFirst Affiliated Hospital of GuangXi Medical UniversityActive in the last 2 years
Fumio Shimamoto
Matched on OpenAlex author ID A5027785421. Sources: OpenAlex.
Their work
- Papers
- 2 (first author 0, last author 2)
- Trials
- 0
- Grants
- 0
- Labs led
- 1
- Collaborators
- 2
2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper
Papers 2
- Retraction Note: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Last author DOI 10.1186/s12943-025-02432-5↗
- m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt signaling. Last author DOI 10.1186/s12943-019-1128-6↗
Closest collaborators
The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Bo Tang · 2 shared papers, 2020–2025 · strength 0.39
- Paper Retraction Note: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation an… DOI 10.1186/s12943-025-02432-5↗
- Paper m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt s… DOI 10.1186/s12943-019-1128-6↗
- Songqing He · 2 shared papers, 2020–2025 · strength 0.39
- Paper Retraction Note: m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation an… DOI 10.1186/s12943-025-02432-5↗
- Paper m6A demethylase ALKBH5 inhibits pancreatic cancer tumorigenesis by decreasing WIF-1 RNA methylation and mediating Wnt s… DOI 10.1186/s12943-019-1128-6↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.